The Second Academic Committee of the State Key Laboratory of Quality Research in Chinese Medicine (SKL-QRCM) held its eighth meeting at the University of Macau (UM). The meeting, held in a hybrid format, was attended by Ip Kuai Lam, member of the Administrative Committee of the Science and Technology Development Fund of Macao; Lee Hun Wei, president of the Macau University of Science and Technology (MUST); Ge Wei, vice rector of UM; Chen Kaixian and Ding Jian, directors of the Academic Committee; as well as other committee members and laboratory members.
During the meeting, Ip, Lee, and Ge delivered welcoming speeches, followed by speeches by Chen and Ding. Chen Xin, Distinguished Professor at UM and director of SKL-QRCM (UM), presented to the committee the progress of SKL-QRCM in 2023 on behalf of both SKL-QRCM (UM) and SKL-QRCM (MUST). According to Chen, SKL-QRCM, by focusing on technological innovation and the development needs of the Chinese medicine industry in Macao, made significant achievements in various areas in 2023, including Chinese medicine quality assessment, identification of new pathogenesis and targets, international collaborations, publications, and patents. In addition, with the support of SKL-QRCM, the first phase of assessment for the construction of Macao Centre for Research and Development in Chinese Medicine was successfully completed, and Macao Centre for Testing of Chinese Medicine obtained accreditation from China National Accreditation Service for Conformity Assessment. The Academic Committee acknowledged the achievements SKL-QRCM made in 2023, particularly its progress in technological collaborations between UM and MUST. Moreover, members of the committee provided valuable suggestions for the future development of SKL-QRCM.
